Literature DB >> 16079306

Overexpression of des(1-3) insulin-like growth factor 1 in the mammary glands of transgenic mice delays the loss of milk production with prolonged lactation.

Darryl L Hadsell1, Daniel T Torres, Nicole A Lawrence, Jessy George, Albert F Parlow, Adrian V Lee, Marta L Fiorotto.   

Abstract

During prolonged lactation, the mammary gland gradually loses the capacity to produce milk. In agricultural species, this decline can be slowed by administration of exogenous growth hormone (GH), which is believed to act through insulin-like growth factor 1 (IGF1). Our previous work demonstrated delayed natural mammary gland involution in des(1-3)IGF1-overexpressing transgenic mice (Tg[Wap-des{1-3}IGF1]8266 Jmr), hereafter referred to as WAP-DES mice. The present study tested the hypothesis that overexpressed des(1-3)IGF1 would delay the loss of milk production during prolonged lactation. Accordingly, we examined lactational performance in WAP-DES mice by artificially prolonging lactation with continual litter cross-fostering. Over time, lactational capacity and mammary development declined in both WAP-DES and control mice. However, the rate of decline was 40% slower in WAP-DES mice. Mammary cell apoptosis increased by 3-fold in both groups during prolonged lactation but was not different between genotypes. Plasma concentrations of murine IGF1 were decreased in WAP-DES mice, while those of the transgenic human IGF1 were elevated during prolonged lactation. Phosphorylation of the mammary IGF1 receptor was increased in the WAP-DES mice, but only during prolonged lactation. Plasma prolactin decreased with prolonged lactation in nontransgenic mice but remained high in WAP-DES mice. The WAP-DES mice maintained a higher body mass and a greater lean body mass during prolonged lactation. These data support the conclusion that overexpressed des(1-3)IGF1 enhanced milk synthesis and mammary development during prolonged lactation through localized and direct activation of the mammary gland IGF1 receptor and through systemic effects on prolactin secretion and possibly nutrient balance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079306     DOI: 10.1095/biolreprod.105.043992

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  11 in total

1.  Elevated circulating IGF-I promotes mammary gland development and proliferation.

Authors:  Dara Cannata; Danielle Lann; Yingjie Wu; Sebastien Elis; Hui Sun; Shoshana Yakar; Deborah A Lazzarino; Teresa L Wood; Derek Leroith
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

Review 2.  The declining phase of lactation: peripheral or central, programmed or pathological?

Authors:  Darryl Hadsell; Jessy George; Daniel Torres
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 3.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

4.  Short-term administration of rhGH increases markers of cellular proliferation but not milk protein gene expression in normal lactating women.

Authors:  Patricia D Maningat; Partha Sen; Monique Rijnkels; Darryl L Hadsell; Molly S Bray; Morey W Haymond
Journal:  Physiol Genomics       Date:  2011-01-04       Impact factor: 3.107

Review 5.  Milk lipid regulation at the maternal-offspring interface.

Authors:  Dengbao Yang; HoangDinh Huynh; Yihong Wan
Journal:  Semin Cell Dev Biol       Date:  2017-10-24       Impact factor: 7.727

6.  In silico QTL mapping of maternal nurturing ability with the mouse diversity panel.

Authors:  D L Hadsell; J Wei; W Olea; L A Hadsell; A Renwick; P C Thomson; M Shariflou; P Williamson
Journal:  Physiol Genomics       Date:  2012-07-03       Impact factor: 3.107

Review 7.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

8.  Production GH transgenic goat improving mammogenesis by somatic cell nuclear transfer.

Authors:  Q Zhang; J Q Chen; J Lin; Q H Yu; H Q Yu; X J Xu; G H Liu; Q Yang
Journal:  Mol Biol Rep       Date:  2014-04-06       Impact factor: 2.316

Review 9.  The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.

Authors:  Robert A Jones; Roger A Moorehead
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-11       Impact factor: 2.673

Review 10.  Mammary involution and breast cancer risk: transgenic models and clinical studies.

Authors:  Derek C Radisky; Lynn C Hartmann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-30       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.